Absher Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Absher Wealth Management's PFE Position: Q4 2025 in Review
Absher Wealth Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,970 shares — an estimated $203K sold.
Absher Wealth Management first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $750K in Q3 2024. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Absher Wealth Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Absher Wealth Management sold 7,970 Pfizer shares in Q4 2025, an estimated $203K.
- Absher Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
- Absher Wealth Management's Pfizer position peaked at $750K in Q3 2024.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Absher Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.